BioHealth Capital Region – Regional Life Sciences Roundup – October 30, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
The BioHealth Capital Region is seeing a growing connection between financial investment, scientific progress, and the infrastructure needed to bring new treatments to market. This week, QIAGEN announced a $12.1 billion takeover agreement with EQT Private Equity, while Kaigene entered a potential $580.5 million licensing agreement with Celltrion. Both developments highlight how major deals are shaping the future of diagnostics and drug development.
That push toward commercialization is also reflected in the region’s clinical progress. MacroGenics reported encouraging Phase 2 results in gynecologic cancer, while Vanda Pharmaceuticals announced positive Phase 3 results for NEREUS. These advances show how continued research is moving promising therapies closer to potential regulatory and commercial milestones.
But turning scientific progress into real-world impact requires more than funding and clinical results. AstraZeneca appointed Hennie Frick to lead its Virginia operations amid a $4.5 billion manufacturing expansion, while Northwest Biotherapeutics is expanding its technical team. Together, these developments point to a region building not just the next generation of therapies, but also the talent and manufacturing capacity needed to deliver them.
Financial
Tracking the capital moving through the BioHealth Capital Region — funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.
QIAGEN and EQT Announce $12.1 Billion Takeover Agreement
One of the life sciences industry’s biggest proposed acquisitions could take QIAGEN private in a $12.1 billion deal with EQT Private Equity. What could the takeover mean for the diagnostics giant’s future innovation, operations, and global growth? Read More >
St. Mary’s College of Maryland Wins $495K NIH Grant for Neuroscience Research
A nearly $500,000 NIH grant is opening new doors for undergraduate neuroscience research at St. Mary’s College of Maryland. The funding will give 24 students access to advanced brain research technologies and a unique collaboration with the Allen Institute Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Senate President Bill Ferguson Names Sen. Brian Feldman Maryland’s Senate Economic Development Chief at TEDCO Entrepreneur Expo
A leadership announcement at TEDCO’s Entrepreneur Expo signals a new chapter for Maryland’s economic development priorities. Senator Brian Feldman’s appointment could shape how the state supports innovation and emerging industries. Read More >
From Korea to the U.S.: Four Health-Tech Companies Looking Across Borders
Four South Korean health-tech startups are setting their sights on the U.S. market, bringing innovations in longevity research, rapid diagnostics, sleep technology, and medical testing. At a BioBuzz and PwC event during DC Tech Startup Week, the founders explored what it takes to turn promising healthcare technologies into successful businesses across borders. Read More >
Katrina Downie Joins Thermo Fisher Scientific
Thermo Fisher Scientific has welcomed Katrina Downie into a key North American commercial leadership role. Her appointment comes as the company continues supporting biopharma manufacturing and customer partnerships. Read More >
Amanda Macedo Joins HJF
The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) has welcomed Amanda Macedo, Ph.D., as Head Humoral Immunology Scientist. Her appointment brings new scientific leadership to the Bethesda-based organization’s immunology research efforts. Read More >
Hennie Frick Named Virginia Site Lead at AstraZeneca
AstraZeneca has appointed Hennie Frick to lead its Virginia operations as the company advances a $4.5 billion manufacturing facility near Charlottesville. Bringing nearly 25 years of experience at GSK, Frick will help oversee a major expansion of the pharmaceutical giant’s U.S. manufacturing footprint. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.
LUNGevity Foundation Launches Multi-Year Research Program within Its Small Cell Lung Cancer Initiative
Small cell lung cancer remains one of the most challenging forms of the disease to treat, but a new research initiative is targeting critical gaps in care. Washington, D.C.-based LUNGevity Foundation is launching a multi-year program focused on advancing treatment strategies and improving outcomes for patients. Read More >
Northwest Biotherapeutics Expands Technical Team to Support U.S. Manufacturing Restart
Bethesda-based Northwest Biotherapeutics is expanding its U.S. technical team as it prepares to restart domestic manufacturing of its personalized cancer vaccines. The new hires will support production scale-up and preparations for clinical trials exploring the company’s immunotherapies in cancers beyond brain cancer Read More >
AstraZeneca Invests in Frederick County’s Long-Term Success
AstraZeneca’s $2 billion Maryland manufacturing investment is creating new opportunities for life sciences professionals in Frederick County. One employee’s journey from intern to associate director highlights how the company is building long-term careers alongside its expanding operations. Read More >
Who’s hiring?!
Top Employer
Dedicated to accelerating the development of life-changing therapies, Precision for Medicine combines clinical research, laboratory expertise, and advanced data science to help bring innovative treatments to patients. With a significant presence in Frederick, Maryland, the company supports drug development across oncology, rare diseases, and cell and gene therapies.
Precision for Medicine’s teams work at the intersection of science and innovation, contributing to clinical trials, biomarker research, and precision medicine solutions that advance patient care. The company offers career opportunities across Clinical Operations, Laboratory Sciences, Data Management, Regulatory Affairs, and Project Management, providing professionals with the chance to make a meaningful impact on the future of medicine.
They are currently hiring across 70+ roles across Maryland. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Novo Nordisk (Petersburg, VA) is hiring a Maintenance Technician III | Apply Now >
- AstraZeneca (Rockville, MD) is hiring a Specialist, Quality Control Analytical, Cell Therapy | Apply Now >
- Amgen (Charlottesville, VA) is hiring a District Manager Primary Care | Apply Now >
- Johnson & Johnson (Richmond, VA) is hiring an Oncology Sales Specialist, CAR-T | Apply Now >
- ICON PLC (Maryland) is hiring a Research Technician | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.
MacroGenics Reports Positive Phase 2 Results in Advanced Gynecologic Cancer
After a clinical safety hold, MacroGenics is reporting promising early results from its Phase 2 LINNET trial. New findings in patients with difficult-to-treat gynecologic cancers offer a closer look at the therapy’s potential. Read More >
RIVANNA Receives FDA Clearance for AI-Powered Bone Imaging Technology
Charlottesville-based RIVANNA has secured FDA clearance for new AI-powered imaging capabilities. The milestone could help expand how ultrasound technology is used in clinical settings. Read More >
Vanda Pharmaceuticals Reports Positive Phase 3 Results for NEREUS
A new treatment could help patients manage one of the most common side effects of GLP-1 weight-loss medications. Washington, D.C. based Vanda Pharmaceuticals reported promising Phase III results for NEREUS, reducing vomiting by 27% as the company prepares to pursue expanded FDA approval. Read More >
Ecosystem
The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure — and the organizations driving it forward.
Virginia’s PAK BioSolutions and iBET Advance Continuous Gene Therapy Manufacturing
Could continuous manufacturing help overcome one of gene therapy’s biggest production challenges? Virginia-based PAK BioSolutions and iBET have demonstrated a purification process that maintained stable operation for 12 hours and achieved 79% full-capsid content, offering a promising approach to more efficient gene therapy manufacturing. Read More >
Kaigene Enters into Exclusive Global Licensing Agreement with Celltrion
A Rockville biotech company has secured a global licensing agreement potentially worth more than $580 million. The deal could significantly expand the reach of Kaigene’s experimental treatment for autoimmune disease. Read More >
Senseonics Initiates First-in-Human Study of Freedom
Senseonics is taking a major step toward making continuous glucose monitoring more seamless. Its latest clinical study is testing technology that could eliminate the need for a wearable transmitter. Read More >
CRB Named ISPE Company of the Year for Fourth Time
Four wins, one industry first. CRB has become the first company to earn ISPE’s Company of the Year Award four times, with its latest recognition announced in Washington, D.C. The honor highlights the company’s contributions to advancing pharmaceutical manufacturing and life sciences innovation. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.
Shredding ADHD Stigma with Supernus Pharmaceuticals
Two-time Olympic gold medalist Chloe Kim is partnering with Rockville-based Supernus Pharmaceuticals to challenge misconceptions about ADHD in women. Through the company’s Qelbree “Ms. Represented” campaign, Kim is sharing her experience with adult ADHD to spotlight a condition that often goes unrecognized in women. Read More >
“Forever Chemicals” Need Not Be Forever
Could bacteria hold the key to breaking down toxic “forever chemicals”? University of Maryland researchers are exploring how microbes could tackle persistent PFAS contamination, offering a potential new approach to protecting human health and the environment. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.
NIH: Panel & Meet-and-Greet
Tuesday, November 3 • 1 – 2 PM • Bethesda, MD
Hosted by Henry M. Jackson Foundation (HJF) | Register Now >
Women’s Health Nexus 2026
Thursday, November 5 | 1:45 – 9:30 PM | Bethesda, MD
Hosted by Women’s Health Nexus | Register Now >
Accelerating Anti-Cancer Agent Development and Validation Workshop
Thursday–Friday, November 5–6 | North Bethesda, MD + Virtual
Hosted by AAADV | Register Now >
